We were simultaneously stopping the growth of new cancer cells and killing those already existing. This was most dramatic when we used the TPA/ATRA combination on the tumors.

We had previously demonstrated that ATRA is an effective synergist with TPA in treating prostate cancer in the laboratory so it was logical to test the combination against pancreatic cancer as well. We found that the TPA/ATRA combination in cell culture worked better than the individual compounds alone.

Pancreas cancer is a tough one to treat. Treatment options are very limited, and not many people survive. TPA has good potential for therapy so it's definitely worth pursuing.

Coming off such a low base, higher rates are confirmation we're in an economic growth cycle, as opposed to killing off the growth cycle, ... It doesn't deter my confidence in the stock market now.

Uncontrolled cell growth is the hallmark of cancer.

Preliminary evidence suggests that these compounds may have some biological activity in slowing the growth of bladder cancer cells.